Tepeza IV infusion 500mg, manufactured by Amgen, contains teprotumumab (genetical recombination) and is indicated for the treatment of Thyroid Eye Disease (TED) in adults. This 500mg 1 bottle formulation (YJ code: 1390400D1026) works as an insulin-like growth factor-1 receptor inhibitor to reduce swelling behind the eye and target the autoimmune mechanisms of TED.
Tepeza IV infusion 500mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
